Parenteral diphosphonates for treating malignant hypercalcemia
- PMID: 6456809
- DOI: 10.1002/1097-0142(19811015)48:8<1922::aid-cncr2820480833>3.0.co;2-2
Parenteral diphosphonates for treating malignant hypercalcemia
Abstract
Two diphosphonates, EHDP (disodium etidronate, or ethanehydroxy-diphosphonate) and Cl2MDP (disodium clodronate, or dichloromethylene-diphosphonate) were injected in various doses in six patients with one or multiple episodes of malignant hypercalcemia. All patients responded well to the drugs after a delay period of two to seven days. The tolerance of the drugs was excellent. EHDP, and especially Cl2MDP, are promising agents for treating hypercalcemia and inhibiting bone resorption in malignant disorders.
Similar articles
-
[Treatment of hypercalcemia of tumoral origin with two diphosphonates].Schweiz Med Wochenschr. 1980 Nov 29;110(48):1822-4. Schweiz Med Wochenschr. 1980. PMID: 6792698 French.
-
Comparison of two parenteral diphosphonates in hypercalcemia of malignancy.Am J Med. 1982 Feb;72(2):221-6. doi: 10.1016/0002-9343(82)90813-0. Am J Med. 1982. PMID: 6460442
-
Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate.Ann Intern Med. 1981 Mar;94(3):312-6. doi: 10.7326/0003-4819-94-3-312. Ann Intern Med. 1981. PMID: 6452846
-
Use of bisphosphonates in cancer patients.Cancer Treat Rev. 1996 Jul;22(4):265-87. doi: 10.1016/s0305-7372(96)90020-1. Cancer Treat Rev. 1996. PMID: 9025784 Review. No abstract available.
-
[Bisphosphonates. Drugs for the treatment of disorders of calcium and bone metabolism].Internist (Berl). 1992 Jun;33(6):441-5. Internist (Berl). 1992. PMID: 1385800 Review. German. No abstract available.
Cited by
-
Treatment of malignant hypercalcaemia with clodronate.Br J Cancer. 1985 May;51(5):665-9. doi: 10.1038/bjc.1985.100. Br J Cancer. 1985. PMID: 3158326 Free PMC article.
-
Influence of dichloromethylene bisphosphonate on the in vitro phagocytosis of hydroxyapatite particles by rat peritoneal exudate cells: an electron microscopic and chemiluminescence study.Ann Rheum Dis. 1992 Feb;51(2):203-9. doi: 10.1136/ard.51.2.203. Ann Rheum Dis. 1992. PMID: 1532298 Free PMC article.
-
Histomorphometric analysis of osteoclastic bone resorption in metastatic bone disease from various primary malignomas.Virchows Arch A Pathol Anat Histopathol. 1986;409(6):817-28. doi: 10.1007/BF00710766. Virchows Arch A Pathol Anat Histopathol. 1986. PMID: 3094242
-
Reduction in calcium excretion in women with breast cancer and bone metastases using the oral bisphosphonate pamidronate.Br J Cancer. 1990 Jan;61(1):123-5. doi: 10.1038/bjc.1990.25. Br J Cancer. 1990. PMID: 2297483 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical